WithdrawnNCT03740243
Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology
Medication studyAges 18+Addiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 30, 2018
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Stony Brook University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Not clearly listed
- Age range
- Over 18 Years
- Official registry ID
- NCT03740243
- Official title
Show the full official title
Comparison of Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Stony Brook University, a university.
Does this study involve medication?
Yes. The study involves medication, including Buprenorphine/naloxone and Buprenorphine.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
